HIF1A encodes the oxygen-regulated transcription factor Hif-1α that controls a number of pathways involved in GBM aggressiveness [34], whose overexpression was observed in GBM patients with poor prognosis and low sensitivity to chemotherapy [37]. Here, HIF1A is linked to glioblastoma.